Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9272 |
High Similarity |
NPD2801 |
Approved |
0.9272 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9205 |
High Similarity |
NPD1934 |
Approved |
0.9184 |
High Similarity |
NPD1511 |
Approved |
0.906 |
High Similarity |
NPD1512 |
Approved |
0.9026 |
High Similarity |
NPD3882 |
Suspended |
0.8867 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8867 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8758 |
High Similarity |
NPD3818 |
Discontinued |
0.875 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.875 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.875 |
High Similarity |
NPD6166 |
Phase 2 |
0.8718 |
High Similarity |
NPD3817 |
Phase 2 |
0.8701 |
High Similarity |
NPD4380 |
Phase 2 |
0.8608 |
High Similarity |
NPD7075 |
Discontinued |
0.8589 |
High Similarity |
NPD7054 |
Approved |
0.8537 |
High Similarity |
NPD7472 |
Approved |
0.8537 |
High Similarity |
NPD7074 |
Phase 3 |
0.8535 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8514 |
High Similarity |
NPD1510 |
Phase 2 |
0.85 |
High Similarity |
NPD5494 |
Approved |
0.8493 |
Intermediate Similarity |
NPD943 |
Approved |
0.8471 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8467 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8456 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8428 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8418 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.84 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.84 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8395 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8375 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8373 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8367 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8354 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8323 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8312 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8291 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8274 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8274 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8255 |
Intermediate Similarity |
NPD1607 |
Approved |
0.825 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.821 |
Intermediate Similarity |
NPD919 |
Approved |
0.8187 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8144 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8144 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8117 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8113 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.811 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8092 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7973 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7964 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7947 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7941 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7935 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7935 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7935 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7927 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7925 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7925 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7914 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7908 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7908 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7905 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7867 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7806 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7799 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7792 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7792 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.779 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7763 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7755 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7742 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7742 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7716 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7712 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7712 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7702 |
Intermediate Similarity |
NPD920 |
Approved |
0.7692 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7688 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7688 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7688 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7682 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7673 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7667 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7662 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7658 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7658 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7651 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7644 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7632 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.763 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7625 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.761 |
Intermediate Similarity |
NPD2309 |
Approved |
0.76 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7584 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7564 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7547 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7514 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7451 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.745 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7439 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7432 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7416 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7386 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7383 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7342 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7317 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7308 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7296 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7296 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7296 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7296 |
Intermediate Similarity |
NPD5405 |
Approved |
0.729 |
Intermediate Similarity |
NPD411 |
Approved |
0.7289 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7288 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7284 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7279 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7267 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7267 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7263 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7262 |
Intermediate Similarity |
NPD37 |
Approved |
0.7261 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7235 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7235 |
Intermediate Similarity |
NPD4966 |
Approved |
0.723 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7228 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7228 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7225 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7207 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7207 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7197 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.719 |
Intermediate Similarity |
NPD3267 |
Approved |
0.719 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7189 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7189 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7184 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7182 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7171 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7159 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7152 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7128 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7128 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7128 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7128 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7128 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7128 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7128 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7126 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7126 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7124 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7115 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7105 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7099 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7091 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7088 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7079 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7078 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7076 |
Intermediate Similarity |
NPD2296 |
Approved |
0.707 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7067 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7048 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7048 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7048 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7045 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7044 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7039
|
Intermediate Similarity |
NPD3823 |
Discontinued |